vs
Side-by-side financial comparison of SONIC AUTOMOTIVE INC (SAH) and Zoetis (ZTS). Click either name above to swap in a different company.
SONIC AUTOMOTIVE INC is the larger business by last-quarter revenue ($3.9B vs $2.4B, roughly 1.6× Zoetis). Zoetis runs the higher net margin — 25.3% vs 1.2%, a 24.1% gap on every dollar of revenue. On growth, Zoetis posted the faster year-over-year revenue change (3.0% vs -0.6%). Zoetis produced more free cash flow last quarter ($732.0M vs $-195.6M). Over the past eight quarters, SONIC AUTOMOTIVE INC's revenue compounded faster (7.0% CAGR vs 4.4%).
Sonic Automotive is a Fortune 500 company based in Charlotte, North Carolina, and is the fifth largest automotive retailer in the United States as measured by total revenues. The company was founded by O Bruton Smith and completed its initial public offering on the NYSE in 1997.
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
SAH vs ZTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9B | $2.4B |
| Net Profit | $46.9M | $603.0M |
| Gross Margin | 15.5% | 70.2% |
| Operating Margin | 3.2% | 31.9% |
| Net Margin | 1.2% | 25.3% |
| Revenue YoY | -0.6% | 3.0% |
| Net Profit YoY | -20.0% | 3.8% |
| EPS (diluted) | $1.39 | $1.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9B | $2.4B | ||
| Q3 25 | $4.0B | $2.4B | ||
| Q2 25 | $3.7B | $2.5B | ||
| Q1 25 | $3.7B | $2.2B | ||
| Q4 24 | $3.9B | $2.3B | ||
| Q3 24 | $3.5B | $2.4B | ||
| Q2 24 | $3.5B | $2.4B | ||
| Q1 24 | $3.4B | $2.2B |
| Q4 25 | $46.9M | $603.0M | ||
| Q3 25 | $46.8M | $721.0M | ||
| Q2 25 | $-45.6M | $718.0M | ||
| Q1 25 | $70.6M | $631.0M | ||
| Q4 24 | $58.6M | $581.0M | ||
| Q3 24 | $74.2M | $682.0M | ||
| Q2 24 | $41.2M | $624.0M | ||
| Q1 24 | $42.0M | $599.0M |
| Q4 25 | 15.5% | 70.2% | ||
| Q3 25 | 15.5% | 71.5% | ||
| Q2 25 | 16.5% | 73.6% | ||
| Q1 25 | 15.5% | 72.0% | ||
| Q4 24 | 14.7% | 69.5% | ||
| Q3 24 | 15.6% | 70.6% | ||
| Q2 24 | 15.6% | 71.7% | ||
| Q1 24 | 15.8% | 70.6% |
| Q4 25 | 3.2% | 31.9% | ||
| Q3 25 | 3.1% | 37.0% | ||
| Q2 25 | -0.6% | 36.7% | ||
| Q1 25 | 4.0% | 36.5% | ||
| Q4 24 | 3.4% | 31.6% | ||
| Q3 24 | 3.3% | 36.6% | ||
| Q2 24 | 3.1% | 33.0% | ||
| Q1 24 | 3.2% | 34.1% |
| Q4 25 | 1.2% | 25.3% | ||
| Q3 25 | 1.2% | 30.0% | ||
| Q2 25 | -1.2% | 29.2% | ||
| Q1 25 | 1.9% | 28.4% | ||
| Q4 24 | 1.5% | 25.1% | ||
| Q3 24 | 2.1% | 28.6% | ||
| Q2 24 | 1.2% | 26.4% | ||
| Q1 24 | 1.2% | 27.4% |
| Q4 25 | $1.39 | $1.37 | ||
| Q3 25 | $1.33 | $1.63 | ||
| Q2 25 | $-1.34 | $1.61 | ||
| Q1 25 | $2.04 | $1.41 | ||
| Q4 24 | $1.67 | $1.29 | ||
| Q3 24 | $2.13 | $1.50 | ||
| Q2 24 | $1.18 | $1.37 | ||
| Q1 24 | $1.20 | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.3M | — |
| Total DebtLower is stronger | $1.6B | — |
| Stockholders' EquityBook value | $1.1B | $3.3B |
| Total Assets | $6.0B | $15.5B |
| Debt / EquityLower = less leverage | 1.51× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.3M | — | ||
| Q3 25 | $89.4M | $2.1B | ||
| Q2 25 | $110.4M | $1.4B | ||
| Q1 25 | $64.6M | $1.7B | ||
| Q4 24 | $44.0M | $2.0B | ||
| Q3 24 | $17.6M | $1.7B | ||
| Q2 24 | $67.2M | $1.6B | ||
| Q1 24 | $15.1M | $2.0B |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.7B | — | ||
| Q1 24 | $1.7B | — |
| Q4 25 | $1.1B | $3.3B | ||
| Q3 25 | $1.1B | $5.4B | ||
| Q2 25 | $1.0B | $5.0B | ||
| Q1 25 | $1.1B | $4.7B | ||
| Q4 24 | $1.1B | $4.8B | ||
| Q3 24 | $1.0B | $5.2B | ||
| Q2 24 | $944.7M | $5.0B | ||
| Q1 24 | $904.4M | $5.1B |
| Q4 25 | $6.0B | $15.5B | ||
| Q3 25 | $6.0B | $15.2B | ||
| Q2 25 | $5.9B | $14.5B | ||
| Q1 25 | $5.9B | $14.1B | ||
| Q4 24 | $5.9B | $14.2B | ||
| Q3 24 | $5.8B | $14.4B | ||
| Q2 24 | $5.8B | $14.2B | ||
| Q1 24 | $5.4B | $14.3B |
| Q4 25 | 1.51× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | 1.67× | — | ||
| Q2 24 | 1.81× | — | ||
| Q1 24 | 1.83× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $66.9M | $893.0M |
| Free Cash FlowOCF − Capex | $-195.6M | $732.0M |
| FCF MarginFCF / Revenue | -5.1% | 30.7% |
| Capex IntensityCapex / Revenue | 6.8% | 6.7% |
| Cash ConversionOCF / Net Profit | 1.43× | 1.48× |
| TTM Free Cash FlowTrailing 4 quarters | $192.3M | $2.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.9M | $893.0M | ||
| Q3 25 | $167.9M | $938.0M | ||
| Q2 25 | $136.8M | $486.0M | ||
| Q1 25 | $195.8M | $587.0M | ||
| Q4 24 | $87.7M | $905.0M | ||
| Q3 24 | $87.8M | $951.0M | ||
| Q2 24 | $-136.4M | $502.0M | ||
| Q1 24 | $70.1M | $595.0M |
| Q4 25 | $-195.6M | $732.0M | ||
| Q3 25 | $134.4M | $805.0M | ||
| Q2 25 | $102.7M | $308.0M | ||
| Q1 25 | $150.8M | $438.0M | ||
| Q4 24 | $-245.5M | $689.0M | ||
| Q3 24 | $34.5M | $784.0M | ||
| Q2 24 | $-185.2M | $370.0M | ||
| Q1 24 | $26.3M | $455.0M |
| Q4 25 | -5.1% | 30.7% | ||
| Q3 25 | 3.4% | 33.5% | ||
| Q2 25 | 2.8% | 12.5% | ||
| Q1 25 | 4.1% | 19.7% | ||
| Q4 24 | -6.3% | 29.7% | ||
| Q3 24 | 1.0% | 32.8% | ||
| Q2 24 | -5.4% | 15.7% | ||
| Q1 24 | 0.8% | 20.8% |
| Q4 25 | 6.8% | 6.7% | ||
| Q3 25 | 0.8% | 5.5% | ||
| Q2 25 | 0.9% | 7.2% | ||
| Q1 25 | 1.2% | 6.7% | ||
| Q4 24 | 8.6% | 9.3% | ||
| Q3 24 | 1.5% | 7.0% | ||
| Q2 24 | 1.4% | 5.6% | ||
| Q1 24 | 1.3% | 6.4% |
| Q4 25 | 1.43× | 1.48× | ||
| Q3 25 | 3.59× | 1.30× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | 2.77× | 0.93× | ||
| Q4 24 | 1.50× | 1.56× | ||
| Q3 24 | 1.18× | 1.39× | ||
| Q2 24 | -3.31× | 0.80× | ||
| Q1 24 | 1.67× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SAH
| Retail New Vehicles | $1.9B | 48% |
| Other | $1.2B | 31% |
| Parts Serviceand Collision Repair | $515.2M | 13% |
| Finance Insurance And Other Net | $202.2M | 5% |
| Wholesale Vehicles | $63.9M | 2% |
| Fleet New Vehicles | $24.0M | 1% |
ZTS
| Other | $1.3B | 56% |
| Livestock | $234.0M | 10% |
| Pain Sedation | $209.0M | 9% |
| Other Pharmaceuticals | $188.0M | 8% |
| Swine | $125.0M | 5% |
| Poultry | $117.0M | 5% |
| Fish | $81.0M | 3% |
| Other Non Pharmaceuticals | $70.0M | 3% |
| Manufactured Product Other | $18.0M | 1% |
| Medicated Feed Additives | $12.0M | 1% |
